Farida Shabbir Akhtari
Works (6)
2021 article
Extending the lymphoblastoid cell line model for drug combination pharmacogenomics
Green, A. J., Anchang, B., Akhtari, F. S., Reif, D. M., & Motsinger-Reif, A. (2021, May 28). PHARMACOGENOMICS, Vol. 22.
author keywords: combination treatment; drug response; LCLs; omics; synergism
Sources: Web Of Science, ORCID
Added: May 29, 2021
2021 journal article
High-throughput screening and genome-wide analyses of 44 anticancer drugs in the 1000 Genomes cell lines reveals an association of the NQO1 gene with the response of multiple anticancer drugs
PLOS GENETICS, 17(8).
Ed(s): F. Vazquez
journals.plos.org (publisher PDF)
Sources: Web Of Science, ORCID
Added: August 27, 2021
2021 journal article
Race and smoking status associated with paclitaxel drug response in patient-derived lymphoblastoid cell lines
PHARMACOGENETICS AND GENOMICS, 31(2), 48–52.
author keywords: dose-response; lymphoblastoid cell lines; paclitaxel; patient-derived cell lines; pharmacogenomics; smoking
Source: Web Of Science
Added: May 10, 2021
2019 journal article
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
NATURE COMMUNICATIONS, 10.
Source: Web Of Science
Added: July 1, 2019
2018 journal article
Pharmacogenetic Analysis of the Model-Based Pharmacokinetics of Five Anti-HIV Drugs: How Does This Influence the Effect of Aging?
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 11(2), 226–236.
Source: Web Of Science
Added: August 6, 2018
2018 journal article
The influence of Neanderthal alleles on cytotoxic response
PEERJ, 6.
author keywords: Neanderthal alleles; Cytotoxic response; Pharmacogenomics; Toxicogenomics; Dose responses; Neanderthal ancestry; Lymphoblastoid cell lines; Anti-cancer drugs; Environmental chemicals; Single nucleotide polymorphisms
Source: Web Of Science
Added: November 5, 2018
